Stay updated on Pembrolizumab for Refractory Esophageal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changed from v3.7.0 to v3.7.1 while the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T22:08:59.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study details, indicating the record is currently inaccessible at this URL. This is an access issue rather than a substantive update to the study information.
    Difference
    19%
    Check dated 2026-09-20T19:39:51.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The revision tag on the page was updated from v3.6.5 to v3.6.6, indicating a newer version of the site’s interface. This is an internal version change and does not imply changes to the study data or eligibility information.
    Difference
    0.1%
    Check dated 2026-08-30T22:23:19.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Updated page revision tag from v3.6.4 to v3.6.5, indicating a minor maintenance update. The visible content and structure of the page remain unchanged.
    Difference
    0.1%
    Check dated 2026-08-09T09:14:09.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.4, replacing Revision: v3.6.3. This reflects a routine page update and does not alter the study information.
    Difference
    0.1%
    Check dated 2026-07-25T18:24:46.000Z thumbnail image
  8. Check
    106 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.3, replacing Revision: v3.6.2 as part of a minor revision to the page's revision history.
    Difference
    0.1%
    Check dated 2026-07-04T10:07:31.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Refractory Esophageal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page.